There is an error in a figure published in the article by Tzouvelekis and colleagues ([@bib1]) that appeared in the February 15, 2017, issue of the *Journal*. In [Figure 3A](#fig3){ref-type="fig"}, the two small boxes on the top left explaining the color coding used in the bar graph were inadvertently reversed because of a printer's error. The box labeled 0 (hours) should be gray and the box labeled 24 (hours) should be black. For the convenience of our readers, we have reproduced the correct version of [Figure 3](#fig3){ref-type="fig"} in its entirety.

![SH2 domain--containing phosphatase-2 (SHP2) negatively regulates fibroblast proliferation and survival *in vitro*. (*A*) Normal human lung fibroblasts (NHLFs) were stimulated with platelet-derived growth factor (PDGF)-BB (25 ng/ml) for 6 hours. PDGF-BB stimulation induced a significant increase (2.7-fold) in proliferation rates of mock- and inactive SHP2 (R465M)-treated cells compared with unstimulated cells. Transfection with active SHP2 (wild-type \[WT\] and E76A) led to a significant decrease in PDGF-BB--induced proliferation (1.2-fold) compared with mock- or R465M-treated cells. Each *bar* represents mean expression of six NHLF samples (biological replicates). Data (ratio of 24 h \[*black bar portion*\] to 0 h \[*gray bar portion*\], absorbance) represent means ± SD. One-way analysis of variance (ANOVA), \**P* \< 0.05. (*B*) NHLFs were treated with the indicated plasmids without growth factor stimulation, and cells were harvested 24 hours afterward for RNA extraction. Shown is the relative change in SHP2, caspase-3 (CASP3), and B-cell CLL/lymphoma 2 (BCL2) mRNA levels. Each *bar and error bar* represents the mean ± SD expression of four samples (biological replicates). *Bars* are shown for the relative changes (fold) by setting the indicated control level to 1.0. One-way ANOVA, \**P* \< 0.05. (*C*) NHLFs were treated with the indicated plasmids, and cells were harvested 48 hours afterward for protein extraction. Shown are immunoblot analyses of SHP2, cleaved (c)-CASP3, and BCL2. Each lane represents an individual NHLF sample. *Vertical black line* indicates that the lanes were run on two different gels. (*D*) Caspase-3/7 activity in NHLFs treated with the indicated plasmids for 48 hours. Data are normalized to caspase-3/7 activity (median absorbance) observed in R465M-treated cells. *Bars* and *error bars* represent mean ± SD activity of four NHLF samples (biological replicates). (*E*) Immunofluorescence analysis for terminal deoxynucleotidyltransferase dUTP nick end labeling (TUNEL)--positive cells after transfection with the indicated plasmids for 48 hours. Samples that were incubated with only the labeling solution were used as negative controls. (*F*) Quantitative scoring of TUNEL/DAPI (4′,6-diamidino-2-phenylindole) double-positive cells as a percentage of total DAPI-positive cells from four NHLF samples (biological replicates). Data represent means ± SD; one-way ANOVA, \**P* \< 0.05. (*G*) SHP2 protein tyrosine phosphatase (PTP) activity in NHLFs transfected with the indicated plasmids for 48 hours. *Bars* and *error bars* represent mean ± SD (nmol/min) activity of two NHLF samples (biological replicates).](rccm.v201erratum3_f3){#fig3}
